Network Immunology Inc.
Entirely novel immune system modification technology platform for transplantation. We have early interest from Pharma for the transplantation technology.
Network Immunology is developing a platform technology for immune system modification.
The technology's indications include degenerative diseases and transplantation.
We plan to be acquired by a large Biotech or Pharma company.
At this stage there is initial interest for our technology from one large Pharma company.